Belite Bio (BLTE) Cash from Investing Activities (2024 - 2025)
Belite Bio (BLTE) posted quarterly Cash from Investing Activities of -$303.7 million for Q4 2025, down 1067.58% year-over-year from $31.4 million in Q4 2024, and down 1067.58% quarter-over-quarter from -$26.0 million in Q4 2024.
Belite Bio (BLTE) Cash from Investing Activities (2024 - 2025) Analysis & Trends
Belite Bio's Cash from Investing Activities history runs 2 years deep, the most recent figure standing at -$303.7 million for Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -45.80 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -92.70 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -1.66 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -49.35 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 19.77 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -229.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -363.46 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 24.51 Mn |
| 10 | Belite Bio | 6.40 Bn | 6.40 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -303.73 Mn |
| Dec 31, 2025 | -303.73 Mn |
| Dec 31, 2024 | -26.01 Mn |
| Dec 31, 2024 | -26.01 Mn |